Edition:
United States

Neogenomics Inc (NEO.OQ)

NEO.OQ on NASDAQ Stock Exchange Capital Market

7.38USD
26 May 2017
Change (% chg)

$-0.17 (-2.25%)
Prev Close
$7.55
Open
$7.50
Day's High
$7.51
Day's Low
$7.33
Volume
43,571
Avg. Vol
93,909
52-wk High
$9.87
52-wk Low
$6.92

NEO.OQ

Chart for NEO.OQ

About

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso... (more)

Overall

Beta: 0.98
Market Cap(Mil.): $613.16
Shares Outstanding(Mil.): 79.22
Dividend: --
Yield (%): --

Financials

  NEO.OQ Industry Sector
P/E (TTM): -- 34.01 30.38
EPS (TTM): -0.39 -- --
ROI: -1.88 5.57 13.36
ROE: -16.29 8.67 14.50

BRIEF-NeoGenomics sees Q2 2017 adjusted earnings per share $0.03-$0.04

* Neogenomics reports 15% volume growth and 10% reduction in average cost per test in the first quarter of 2017

Apr 26 2017

BRIEF-Neogenomics names new Vice President

* Neogenomics appoints Bill Bonello as vice president, treasurer, and director of corporate development Source text for Eikon: Further company coverage:

Apr 20 2017

BRIEF-NeoGenomics and Definiens to develop novel assays for clinical trials & clinical testing

* NeoGenomics and Definiens enter into agreement to develop novel assays for clinical trials & clinical testing

Mar 13 2017

BRIEF-NeoGenomics Q4 GAAP loss per share $0.18

* NeoGenomics reports 122% revenue growth to $60.5 million and 11% reduction in average cost per test in the fourth quarter of 2016

Feb 22 2017

More From Around the Web

Earnings vs. Estimates